What is "quality of evidence" and why is it important to clinicians? - PubMed (original) (raw)

Review

What is "quality of evidence" and why is it important to clinicians?

Gordon H Guyatt et al. BMJ. 2008.

Abstract

Guideline developers use a bewildering variety of systems to rate the quality of the evidence underlying their recommendations. Some are facile, some confused, and others sophisticated but complex

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors are involved in the dissemination of GRADE, and GRADE’s success has a positive influence on their academic career. Authors listed in the byline have received travel reimbursement and honorariums for presentations that included a review of GRADE’s approach to rating quality of evidence and grading recommendations. GHG acts as a consultant to UpToDate; his work includes helping UpToDate in their use of GRADE. HJS is documents editor and methodologist for the American Thoracic Society; one of his roles in these positions is helping implement the use of GRADE. He is supported by “The human factor, mobility and Marie Curie actions scientist reintegration European Commission grant: IGR 42192—GRADE.”

Figures

None

Fig 1 Hierarchy of outcomes according to importance to patients to assess effect of phosphate lowering drugs in patients with renal failure and hyperphosphataemia

None

Fig 2 Downgrading for imprecision: thresholds are key (threshold number needed to treat (NNT) of 200 does not require downgrading whereas the same result with a threshold of 100 requires downgrading)

None

Fig 3 Effect on delayed gastric emptying of pylorus preserving pancreaticoduodenectomy compared with standard Whipple procedure for pancreatic adenocarcinoma

References

    1. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490-4. - PMC - PubMed
    1. Oxman AD, Guyatt GH. Guidelines for reading literature reviews. CMAJ 1988;138:697-703. - PMC - PubMed
    1. Guyatt G, Montori V, Devereaux PJ, Schunemann H, Bhandari M. Patients at the center: in our practice, and in our use of language. ACP J Club 2004;140:A11-2. - PubMed
    1. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001;285:437-43. - PubMed
    1. Ioannidis JP, Lau J. Improving safety reporting from randomised trials. Drug Saf 2002;25:77-84. - PubMed

Publication types

MeSH terms

LinkOut - more resources